The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Attorneys General from several districts have come together in a lawsuit seeking damages from Walgreens for allegedly ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback